TY - JOUR AU - Rudan, Igor AU - Millington, Tristan AU - Antal, Karen AU - Grange, Zoe AU - Fenton, Lynda AU - Sullivan, Christopher AU - Buelo, Audrey AU - Wood, Rachael AU - Woolford, Lana AU - Swann, Olivia V. AU - Murray, Josephine-Louise K. AU - Cullen, L.A. AU - Moore, Emily AU - Haider, Fasih AU - Almaghrabi, Fatima AU - Jim McMenamin AU - Agrawal, Utkarsh AU - Shah, Syed Ahmar AU - Kerr, Steven AU - Simpson, Colin R. AU - Katikireddi, Srinivasa Vittal AU - Ritchie, Sir Lewis D. AU - Robertson, Chris AU - Sheikh, Sir Aziz PY - 2022 DA - September TI - BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland JO - The Lancet Regional Health - Europe VL - 23 DO - https://doi.org/10.1016/j.lanepe.2022.100513 AB - BackgroundThe two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against COVID-19 disease in clinical trials of children and young people (CYP). Consequently, we investigated the uptake, safety, effectiveness and waning of the protective effect of the BNT162b2 against symptomatic COVID-19 in CYP aged 12–17 years in Scotland. PB - Elsevier UR - https://hdl.handle.net/2164/19244 KW - Coronavirus (COVID-19) KW - Children, young people and families KW - Immunisation and screening ER